Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 901-925 of 1,000 matching filings.

Per page
25
Current page
37
8-K File 001-11460

FORM 8-K

Filing date
13 Aug 2012
Reporting date
13 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2012
Reporting date
06 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2012
Reporting date
06 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2012
Reporting date
06 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Jul 2012
Reporting date
02 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
11 Jul 2012
Reporting date
02 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
09 Jul 2012
Reporting date
02 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT ON FORM 8-K

Filing date
13 Jun 2012
Reporting date
08 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Jun 2012
Reporting date
08 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Jun 2012
Reporting date
08 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Jun 2012
Reporting date
08 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
05 Jun 2012
Reporting date
04 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 May 2012
Reporting date
18 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
10 May 2012
Reporting date
10 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-11460

DEFINITIVE PROXY STATEMENT

Filing date
27 Apr 2012
Reporting date
08 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-11460

NTN BUZZTIME, INC.

Filing date
30 Mar 2012
Reporting date
31 Dec 2011
Next action
Verify source filing
8-K File 001-11460

FORM 8K

Filing date
29 Mar 2012
Reporting date
29 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Mar 2012
Reporting date
26 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42217

FORM 13D/A

Filing date
07 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2012
Reporting date
24 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2012
Reporting date
24 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
28 Feb 2012
Reporting date
28 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT ON FORM 8-K

Filing date
22 Feb 2012
Reporting date
22 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-42217

AMENDMENT TO SCHEDULE 13G

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .